European Pharmaceutical Review

APRIL 17, 2023

“I look forward to working with the Prometheus team to establish a new paradigm of precision treatment for immune diseases,” commented Dr Dean Y Li, President of Merck Research Laboratories.

Research Laboratories 105

Research Laboratories Immunization 105

The People's Pharmacy

JUNE 15, 2023

Commins sees patients in the UNC allergy clinic and maintains an active research laboratory. His primary research and clinical interest is alpha-gal syndrome. Patients in the allergy clinic often have difficult to diagnose food allergies or allergic reactions.

Research Laboratories 96

Research Laboratories Immunization 96

STAT

AUGUST 16, 2023

 The company — which is a major supplier of non-human primates to corporate, government, and academic research laboratories — received a voluntary request last May for documents dating back to December 2017 about importing non-human primates from Asia, according to a regulatory filing.

Research Laboratories 96

Research Laboratories Documentation Pharmaceutical Companies Pharmaceutical Companies 96

Pharmaceutical Technology

JULY 13, 2022

Merck Research Laboratories president Dr Dean Li said: “Targeting CYP11A1 provides a compelling approach to suppressing the production of steroid hormones, a key driver of prostate cancer. “We The latest deal complements and bolsters the oncology pipeline of Merck.

Research Laboratories 105

Research Laboratories Vaccines 105

pharmaphorum

JANUARY 28, 2022

. “This approval demonstrates our progress in bringing Keytruda to patients with earlier stages of cancer, with the goal of helping more patients around the globe prevent disease recurrence,” said Scot Ebbinghaus, head of clinical research at Merck Research Laboratories.

Research Laboratories 111

Research Laboratories 111

European Pharmaceutical Review

DECEMBER 15, 2023

The companies also plan to expand the development programme to additional tumour types.

Vaccines 115

Vaccines Research Laboratories Immunization 115

Pharmacy Is Right For Me

APRIL 3, 2023

Pharmacists can work in a variety of settings, including hospitals, community pharmacies, research laboratories, and government agencies. Flexibility in work hours and settings Pharmacy offers a great deal of flexibility in terms of work hours and settings.

Research Laboratories 130

Research Laboratories Community Pharmacies Hospitals 130

European Pharmaceutical Review

OCTOBER 19, 2022

This is our second acquisition in gene therapy, following the 2021 acquisition of Prevail Therapeutics,” added Dr Daniel Skovronsky, Lilly’s Chief Scientific and Medical Officer and President of Lilly Research Laboratories. “With Akouos, we are optimistic that we can make a difference for people with hearing loss.”

Research Laboratories 98

Research Laboratories 98

European Pharmaceutical Review

NOVEMBER 22, 2022

Li, President of Merck Research Laboratories. “We Lysine-specific demethylase 1 (LSD1). Evidence indicates that LSD1 (KDM1A) plays an important role in the maturation of blood cells in the bone marrow,” noted Dr Dean Y.

Research Laboratories 98

Research Laboratories 98

European Pharmaceutical Review

JULY 7, 2022

At the beginning of his career in 2004, Dr Hughes was responsible for early clinical research at Bristol Myers-Squibb Company and then at Schering-Plough Research Institute. Dr Hughes earned his MD and PhD at Yale School of Medicine.

Research Laboratories 98

Research Laboratories Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

European Pharmaceutical Review

NOVEMBER 4, 2022

Co-principal investigator on the study, Dr Jeffrey Petrella, Professor of Radiology and Director of the Alzheimer Imaging Research Laboratory at Duke University added: “It often takes tens of millions of dollars and many years to do a head-to-head comparison of drugs.”.

Research Laboratories 105

Research Laboratories Dosage FDA 105

Pharma Mirror

SEPTEMBER 9, 2021

Multiple flow chemistry platforms have been installed into a research laboratory at the site to allow the investigation of a wide range of chemical processes, including photolysis, electrochemistry and hydrogenations, as well. Announcement of the investment follows the appointment of Professor Ian R.

Research Laboratories 52

Research Laboratories 52

pharmaphorum

APRIL 7, 2022

Dean Li, president of Merck Research Laboratories, told the meeting that cardiovascular disease is a big opportunity as it remains an epidemic, killing 35 million people during the pandemic while COVID-19 claimed the lives of 10 million.

Research Laboratories 98

Research Laboratories 98

BioPharm

NOVEMBER 21, 2022

The Unistat range of temperature control systems ensure accurate temperatures and stable process conditions in research laboratories, pilot plants and kilolabs worldwide. Precise temperature control has a significant influence on performance and quality in chemical process engineering.

Research Laboratories 40

Research Laboratories 40

pharmaphorum

MAY 6, 2021

The company noted that Merck gained more than 100 regulatory approvals during Perlmutter’s seven-year tenure as president of Merck Research Laboratories, before retiring last year.

Research Laboratories 64

Research Laboratories 64

Pharmaceutical Technology

JUNE 7, 2023

Merck Research Laboratories global clinical development vice-president Dr Elizabeth Rhee stated: “PREVYMIS has been an important addition to the care of high-risk adult CMV-seropositive patients who have received allogeneic stem cell transplants to help prevent CMV infection and disease.

FDA 52

FDA Research Laboratories 52

pharmaphorum

APRIL 9, 2021

Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories said in a statement that the data marked the first time an anti-PD-1 therapy showed potential adjuvant treatment for patients with RCC.

Research Laboratories 59

Research Laboratories FDA 59

Pharmaceutical Technology

APRIL 4, 2023

Results showed that patients treated with Padcev along with KEYTRUDA achieved a confirmed ORR of 68%. 12% experienced a complete response and 55% a partial response.

Research Laboratories 52

Research Laboratories Chemotherapy FDA 52

Pharmaceutical Technology

AUGUST 17, 2022

The rights to the oRNA-LNP technology platform of Orna will be retained by the company, which will also progress various other fully owned programmes in oncology and genetic disease areas. In addition, Merck will make a $100m equity investment in Orna’s Series B funding round concluded recently.

Vaccines 59

Vaccines Research Laboratories Packaging 59

Pharmaceutical Technology

DECEMBER 23, 2022

Merck Research Laboratories president Dr Dean Li said: “Advances in ADC technologies are yielding a new generation of candidates designed to more precisely target and deliver potent anticancer agents to the tumour site. Merck will also make tiered royalty payments on net sales for any ADC product commercialised to Kelun-Biotech.

Research Laboratories 52

Research Laboratories 52

Pharmaceutical Technology

SEPTEMBER 28, 2022

Merck Research Laboratories global clinical development head, senior vice-president and chief medical officer Dr Eliav Barr said: “Based on compelling data from our clinical trial programme, Keytruda has become an important treatment option in Japan and now has 23 approved uses across 13 different types of cancer.

Chemotherapy 59

Chemotherapy Research Laboratories Immunization 59

pharmaphorum

MARCH 2, 2021

Keytruda’s other indications remain unaffected, and Roy Baynes, head of global clinical development at Merck Research Laboratories emphasised that Keytruda remains “foundational” for treatment of certain patients with non-small cell lung cancer.

FDA 59

FDA Research Laboratories Chemotherapy 59

Pharmaceutical Technology

MAY 12, 2023

They have also created tissue research images at the IPU and other ICR research laboratories. Researchers at the unit are integrating digital pathology, tissue hybridisation and AI technologies to gain better understanding of major aspects of cancer pathology.

Research Laboratories 52

Research Laboratories Hospitals 52

pharmaphorum

AUGUST 5, 2020

Dr Sam Engel, associate vice president, Merck clinical research, diabetes and endocrinology, Merck Research Laboratories, said: “Data from phase 2 studies has provided compelling clinical evidence that warrants further evaluation of efinopegdutide for the treatment of NASH.”.

Research Laboratories 52

Research Laboratories FDA 52

pharmaphorum

DECEMBER 23, 2022

. “Advances in ADC technologies are yielding a new generation of candidates designed to more precisely target and deliver potent anticancer agents to the tumour site,” said Dean Li, president of Merck Research Laboratories.

Research Laboratories 52

Research Laboratories 52

pharmaphorum

SEPTEMBER 28, 2021

“Frequently diagnosed at an advanced stage, hepatocellular carcinoma has one of the highest mortality rates of solid cancers,” said Merck Research Laboratories’ clinical research head Scot Ebbinghaus. He said the company will “look forward to engaging with regulatory authorities as quickly as possible.”

Research Laboratories 52

Research Laboratories FDA 52

pharmaphorum

OCTOBER 14, 2021

Dr Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories, said the data showing a 36% reduction in the risk of death “are compelling”.

Chemotherapy 45

Chemotherapy Research Laboratories Immunization FDA 45

Pharmaceutical Technology

SEPTEMBER 15, 2022

Take Charleston, South Carolina, for example, where a growing number of medical device and pharmaceutical manufacturers, research laboratories and service companies have sprung up or settled in recent years. In mid-sized Charleston, connections and collaborations are a constant.

Research Laboratories 52

Research Laboratories Patient Care Hospitals 52

Pharmaceutical Technology

JULY 28, 2022

While the life sciences market continues to grow, the 300-plus medical device and pharmaceutical manufacturers, research laboratories and service companies already there can feel confident in the area’s ability to support their future growth and success. Discover why global life sciences businesses are choosing this thriving region.

Research Laboratories 52

Research Laboratories Patient Care 52

The FDA Law Blog

DECEMBER 11, 2023

(“Laboratories that meet these requirements are the only laboratories that can perform LDTs under CLIA regulations, because LDTs are considered high complexity tests”) [3] S&C’s Quality, Certification and Oversight Reports (QCOR), Active CLIA Laboratory Search Database, [link]. [4] 4] PRIA at 28. [5] 68006, 68012 (Oct.

FDA 69

FDA Research Laboratories Documentation 69

European Pharmaceutical Review

JUNE 18, 2024

FDA’s approval offers further confirmation “on the established role of KEYTRUDA in certain types of advanced endometrial carcinoma as monotherapy and in combination with LENVIMA ® (lenvatinib),” commented Dr Gursel Aktan , Vice President, global clinical development, Merck Research Laboratories.

Chemotherapy 105

Chemotherapy Research Laboratories FDA 105

European Pharmaceutical Review

MAY 30, 2024

Advancing the acquisition “By combining our strengths, we aim to advance with rigor and speed the development of their promising pipeline of candidates targeting retinal diseases,” stated Dr Dean Li , President, Merck Research Laboratories. “As

Research Laboratories 96

Research Laboratories 96

European Pharmaceutical Review

AUGUST 18, 2022

We look forward to working with the talented scientific and technical teams at Orna.” ” “We are thrilled to collaborate with Merck, a company committed to breakthrough science, which has recognised the potential our platform can bring to patients.

Vaccines 98

Vaccines Research Laboratories Packaging 98

Pharmaceutical Technology

FEBRUARY 27, 2023

Merck and Ridgeback intend to appeal the decision and request a re-examination of the regulator’s opinion. The scientific opinion of the EMA, which has supported 16 EU national authorities’ decision to make Lagevrio available, remains in effect.

Research Laboratories 64

Research Laboratories 64

European Pharmaceutical Review

AUGUST 12, 2024

The bispecific antibody has shown potential to generate “significant and sustained reductions in B-cell populations”. For example, the data indicates that CN201 is well tolerated and active in relapsed or refractory B-cell haematologic malignancies.

Research Laboratories 59

Research Laboratories Chemotherapy FDA 59

Pharmaceutical Technology

AUGUST 5, 2022

Merck Research Laboratories global clinical development head, senior vice-president and chief medical officer Dr Eliav Barr said: “The approval offers patients with germline BRCA-mutated, HER2-negative early-stage breast cancer a new, much-needed treatment option.

Research Laboratories 59

Research Laboratories Chemotherapy FDA 59

Pharmaceutical Technology

JUNE 23, 2022

Merck Research Laboratories global clinical development senior vice-president, head and chief medical officer Dr Eliav Barr said: “Our goal with Vaxneuvance is to expand coverage of key invasive disease-causing serotypes and provide a strong immune response to serotypes that pose substantial risk to infants and children.

Vaccines 59

Vaccines FDA Research Laboratories Immunization 59